Superpotent Drug: Out Of Specification (OOS) result for Assay.
Prescription Drugs
💊 Drugs • 12,141 recalls
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process
P-P-P (COBAL) 30-1-20/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
Bedford Pharmacy
Lack of assurance of sterility
Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.
Methylcobalamin (preservative Free) 1 mg/mL Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
Bedford Pharmacy
Lack of assurance of sterility
Superpotent Drug: Out Of Specification (OOS) result for Assay.
P-P-P (COBAL) 30-2- 30/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
Bedford Pharmacy
Lack of assurance of sterility
FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4297-31, UPC 3 0054-4297-31 8.
Boehringer Ingelheim Roxane
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
P-P (COBAL)30-0.5/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
Bedford Pharmacy
Lack of assurance of sterility
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Hydroxocobalamin 20 mg/mL Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
Bedford Pharmacy
Lack of assurance of sterility
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
FUROSEMIDE Tablets USP, 40 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4299-31, UPC 3 0054-4299-31 2.
Boehringer Ingelheim Roxane
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.
P-P (COBAL) 300-30/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
Bedford Pharmacy
Lack of assurance of sterility
Superpotent Drug: Out Of Specification (OOS) result for Assay.